N-Glycan Modification in Covid-19 Pathophysiology: In vitro Structural Changes with Limited Functional Effects

Cristiane N. Santos(National Institutes of Health Clinical Center), Sergio D. Rosenzweig(National Institutes of Health)
Journal of Clinical Immunology
November 27, 2020
10.1007/s10875-020-00905-4
Cited by 28

Related Papers

Activated STING in a Vascular and Pulmonary Syndrome
|New England Journal of Medicine|2014|1.4k
Early-Onset Stroke and Vasculopathy Associated with Mutations in ADA2
|New England Journal of Medicine|2014|889
Common Severe Infections in Chronic Granulomatous Disease
|Clinical Infectious Diseases|2014|421
Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy
|JCI Insight|2016|304
Novel nonsense gain-of-function NFKB2 mutations associated with a combined immunodeficiency phenotype
|Blood|2017|82